The Veterinary Record
HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guedes, R. M. C.
Right arrow Articles by da Costa Cruz, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guedes, R. M. C.
Right arrow Articles by da Costa Cruz, E. C., Jr
The Veterinary Record 165:342-345 (2009)
© 2009 British Veterinary Association


Papers

Use of tylvalosin-medicated feed to control porcine proliferative enteropathy

R. M. C. Guedes, DVM, MS, PhD1, S. A. França, DVM, MS1, G. S. Machado, DVM, DrAnimSci2, M. A. Blumer, DVM3 and E. C. da Costa Cruz, Jr, DVM1

1 Department of Clinic and Surgery, Veterinary School, Federal University of Minas Gerais, Avenid Antônio Carlos 6627, PO Box 567, Belo Horizonte, MG 31 270-901, Brazil
2 Integrall-Soluções em Produção Animal, Belo Horizonte, 30310-040, Brazil
3 Sanphar Química e Farmacêutica, Campinas, 13023-101, Brazil

Correspondence: E-mail for correspondence: guedes{at}vet.ufmg.br

The effect of an oral treatment with the tartrate salt of tylvalosin on the development of proliferative enteropathy in 60 experimentally challenged pigs was studied. Thirty of the pigs were fed a diet medicated with 50 ppm tylvalosin and 30 were fed the unmedicated diet. The treated animals started to receive the medicated feed the day before they were inoculated, and continued to receive it for 14 days. The pigs' bodyweight, feed consumption and clinical signs were evaluated, and they were examined postmortem 20 days after inoculation, and samples of ileum were collected for immunohistochemistry (IHC) for Lawsonia intracellularis. Clinical signs of the disease were more evident in the untreated group than in the treated group. The average daily weight gain, average daily feed consumption and feed conversion efficiency were better in the treated group. The combined length of intestine with lesions was 2847 cm in the untreated group and 183 cm in the treated group. The tylvalosin treatment significantly reduced the level of L intracellularis infection; almost half of the treated pigs were IHC-negative compared with 3·3 per cent of the untreated pigs.







HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
Copyright © 2009 British Veterinary Association